Delivery Order SPE2DR25D1100-SPE2DR26FDF1F
Award Date 2/12/26
Potential Completion Date 2/13/26
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Dalvance 500 mg vials, with a ceiling value of $4,807.23.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 12, 2026, and is priced on a firm fixed-price basis.</p>
- <p>The Defense Logistics Agency issued a $5,610.07 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Dalvance 500 mg vials with a firm fixed price.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 9, 2026. No set-aside was used for this order.</p>
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Dalvance 500 mg vials, with a ceiling value of $2,303.03 and an ultimate completion date of November 3, 2025. This non-set-aside contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with a ceiling value of $2,743.74. The award, issued on September 4, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- On January 30, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $40,619.22 to Amerisourcebergen Drug Corp for the supply of Dalvance 500 mg vials, with an ultimate completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract that will be performed at the contractor's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $12,165.60 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4,562 units of 500 mg vials of Dalvance to support the Department of Defense's medical supply needs. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 11-12, 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This firm fixed-price delivery order, valued at $9,459.06, is scheduled for completion by December 29, 2025, with performance taking place at the company's Conshohocken, Pennsylvania facility. The award was made through open competition without any set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,279.48 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Dalvance (dalbavancin) is an antibiotic used to treat acute bacterial skin and skin structure infections, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $8,732.44 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used in hospital and clinical settings. This competitively awarded, firm fixed-price delivery order was issued on September 10, 2025, with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $8,113.73 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication. The contract was competitively awarded without set-aside designation on December 15, 2025, with an ultimate completion date of December 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is priced on a firm fixed price basis,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDF1FDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Dalvance 500 mg vials with a ceiling value of $27,899.21. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 13, 2026, and is priced on a firm fixed-price basis. No set-aside was used.
Generated 5/13/26, 10:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 2/11/26 |